| Code | 3081F | ||||||||||
| MA number | 18/0106/26-S | ||||||||||
| Product Form: | tbl flm 30x5 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | G.L. Pharma GmbH, Austria | ||||||||||
| Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 13.04.2026 |
| Validity: | 13.04.2031 |
| SPC: |
SPC_Liamell 5 mg filmom obalené tablety_tbl flm_03/2026_REG.pdf
|
| PIL: |
PIL_Liamell 5 mg filmom obalené tablety_tbl flm_03/2026_REG.pdf
|
| Safety feature | Yes |
| Data update: | 14.04.2026 |
